Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | PGK1 | P00558 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | HTR2B | P41595 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30211607 | 1.00 | KDM4E (0.34) | KDM4EALDH1A1CYP1A2CYP3A4MAPT | |
| SCHEMBL24892594 | 0.90 | KDM4E (0.34) | KDM4EALDH1A1CYP1A2CYP3A4MAPT | |
| SCHEMBL24892479 | 0.86 | KDM4E (0.39) | KDM4EALDH1A1CYP1A2CYP3A4MAPT | |
| SCHEMBL21114152 | 0.83 | CYP3A4 (0.46) | KDM4EALDH1A1CYP1A2CYP3A4MAPT | |
| SCHEMBL31570490 | 0.83 | CYP3A4 (0.46) | KDM4EALDH1A1CYP1A2CYP3A4MAPT | |
| SCHEMBL257939 | 0.75 | ESR2 (0.37) | — | |
| SCHEMBL21114127 | 0.74 | KDM4E (0.36) | KDM4EALDH1A1CYP1A2CYP3A4MAPT | |
| SCHEMBL22916703 | 0.72 | LPL (0.35) | — | |
| SCHEMBL24206970 | 0.71 | LIPG (0.43) | — | |
| SCHEMBL29202467 | 0.70 | KDM4E (0.41) | KDM4EALDH1A1CYP1A2CYP3A4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117642170-A | Therapeutic compounds and methods | 基因泰克公司 | 2024-03-01 | — | — | CN | disclosed |